Live Breaking News & Updates on Grfs

Stay updated with breaking news from Grfs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Grifols (NASDAQ:GRFS) Trading 6% Higher

Grifols, S.A. (NASDAQ:GRFS – Get Free Report)’s stock price traded up 6% during mid-day trading on Tuesday . The company traded as high as $10.56 and last traded at $10.41. 1,145,465 shares were traded during mid-day trading, an increase of 32% from the average session volume of 869,458 shares. The stock had previously closed at […] ....

United States , Vistaseal Veraseal , Albutein Flexbag , Susquehanna International Securities Ltd , Quadrant Capital Group , Ronald Blue Trust Inc , Grifols Company Profile , Morgan Stanley , Get Free Report , Financial Advisors , Blue Trust , Capital Group , Susquehanna International Securities , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Stock Price Up 6%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) rose 6% during mid-day trading on Tuesday . The company traded as high as $10.56 and last traded at $10.41. Approximately 1,145,465 shares changed hands during trading, an increase of 32% from the average daily volume of 869,458 shares. The stock had previously closed at $9.82. […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , First Trust Advisors , Norges Bank , America Corp , Morgan Stanley , Get Free Report , Trust Advisors , Investment Partners , World Investors , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Trading Down 2%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) were down 2% during mid-day trading on Tuesday . The stock traded as low as $8.54 and last traded at $8.64. Approximately 98,387 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 899,347 shares. The stock had previously closed at […] ....

Alanb Lancz Associates Inc , Grifols Company Profile , Gabelli Funds , Morgan Stanley , Hennion Walsh Asset Management Inc , Get Rating , Walsh Asset Management , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols, S.A. (NASDAQ:GRFS) Receives Consensus Rating of "Moderate Buy" from Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Rating) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective […] ....

Norges Bank , Morgan Stanley , First Trust Advisors , Grifols Company Profile , Get Rating , Marketbeat Ratings , Trust Advisors , Investment Partners , World Investors , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Shares Gap Up to $8.34

Grifols, S.A. (NASDAQ:GRFS – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $8.34, but opened at $8.90. Grifols shares last traded at $8.88, with a volume of 45,725 shares traded. Analysts Set New Price Targets A number of research firms have recently commented on GRFS. Barclays […] ....

Ronald Blue Trust Inc , Quadrant Capital Group , Morgan Stanley , Grifols Company Profile , Susquehanna International Securities Ltd , Get Rating , Financial Advisors , Blue Trust , Capital Group , Susquehanna International Securities , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,